ТЕКНИФАР-ИНДУСТРИА ТЕКНИКА ФАРМАСЬЮТИКА, С.А (PT);ТЕХНОФАГ, ИНВЕСТИГАСАН Э ДЕЗЕНВОЛВИМЕНТО ЭН БИОТЕХНОЛОГИА, СА (PT);ТЕКНИФАР-ИНДУСТРИА ТЕКНИКА ФАРМАСЬЮТИКА; С.А (PT)
发明人:
ДА КОСТА ГАРСИА Мигель Анжело (PT),СОЗА ДЭ САН ЖОЗЕ Карлос Жорже (PT),РОДРИГЕС ЛЕАНДРО Клара Изабель (PT),РОДРИГЕС ПАРДАЛ ДИАС АНТУНЕШ МАРСАЛ ДА СИЛВА Филипа Мария (PT),МАРТИНС БАРБОСА Ана Ракель (PT)
申请号：
RU2013117275/10
公开号：
RU2013117275A
申请日:
2011.09.19
申请国别(地区):
RU
年份:
2014
代理人:
摘要：
1. An isolated bacteriophage having a genome that contains a nucleic acid sequence of SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 560, SEQ ID NO: 781 or SEQ ID NO: 1074.2. A pharmaceutical composition comprising a bacteriophage according to claim 1 and a pharmaceutically acceptable carrier. The pharmaceutical composition according to claim 2, which contains a bacteriophage having a genome that contains a nucleic acid sequence of SEQ ID NO: 1, and further comprises one or more additional bacteriophage strains effective against Klebsiella pneumoniae. The pharmaceutical composition according to claim 2, which contains a bacteriophage having a genome that contains a nucleic acid sequence of SEQ ID NO: 1, and further comprises one or more additional bacteriophage strains effective against bacteria other than Klebsiella pneumoniae. The pharmaceutical composition according to claim 2, which contains a bacteriophage having a genome that contains a nucleic acid sequence of SEQ ID NO: 781, and further comprises one or more additional bacteriophage strains effective against Klebsiella pneumoniae. The pharmaceutical composition according to claim 2, which contains a bacteriophage having a genome that contains a nucleic acid sequence of SEQ ID NO: 781, and further also one or more additional bacteriophage strains effective against bacteria other than Klebsiella pneumoniae. The pharmaceutical composition according to claim 2, which contains a bacteriophage having a genome that contains a nucleic acid sequence of SEQ ID NO: 2, and further comprises one or more additional bacteriophage strains effective against Acinetobacter baumannii. Pharmaceutical to1. Выделенный бактериофаг, имеющий геном, который содержит последовательность нуклеиновой кислоты SEQ ID NO: 1, SEQ ID NO: 2, SEQ ID NO: 3, SEQ ID NO: 4, SEQ ID NO: 560, SEQ ID NO: 781 или SEQ ID NO: 1074.2. Фармацевтическая композиция, содержащая бактериофаг по п.1 и фармацевтически приемлемый носитель.3. Фарм
